Apixaban zur Thrombose-prophylaxe bei Hüftersatz

Steurer, Johann
August 2011
Praxis (16618157);8/10/2011, Vol. 100 Issue 16, p991
Academic Journal
No abstract available.


Related Articles

  • New Anticoagulants and Antiplatelet Agents: A Primer for the Clinical Gastroenterologist. Parekh, Parth J; Merrell, Jonathan; Clary, Meredith; Brush, John E; Johnson, David A // American Journal of Gastroenterology;Jan2014, Vol. 109 Issue 1, p9 

    The discovery of the first oral anticoagulant, warfarin, was a milestone in anticoagulation. Warfarin's well-known limitations, however, have led to the recent development of more effective anticoagulants. The rapidly growing list of these drugs, however, presents a challenge to endoscopists who...

  • PCI in Patients on Warfarin: Do We Need Dual Antiplatelet Therapy? Boyle, Andrew J. // Clinical Cardiology Alert;Jun2013, Vol. 32 Issue 6, p45 

    The article discusses the need of dual antiplatelet therapy (DAPT) in percutaneous coronary intervention (PCI) patients using drug Warfarin. It is mentioned that using oral anticoagulants (OAC) for long duration for atrial fibrillation (AF) and mechanical prosthetic valves, need for DAPT and OAC...

  • High Maintenance Dosage of Clopidogrel is Associated with a Reduced Risk of Stent Thrombosis in Clopidogrel-Resistant Patients. Tavassoli, Neda; Voisin, Sophie; Carrie, Didier; Lapeyre-Mestre, Maryse; Galinier, Michel; Montastruc, Jean Louis; Pathak, Atul // American Journal of Cardiovascular Drugs;2010, Vol. 10 Issue 1, p29 

    Background: Stent thrombosis remains an important complication after stent implantation, despite the use of dual antiplatelet therapy with aspirin (acetylsalicylic acid) and clopidogrel. Several studies have shown an increased risk of thrombotic events in patients with resistance to clopidogrel....

  • Fondaparinux: A Pharmacoeconomic Review of its Use in the Management of Non-ST-Segment Elevation Acute Coronary Syndrome. McKeage, Kate; Lyseng-Williamson, Katherine A. // PharmacoEconomics;2010, Vol. 28 Issue 8, p687 

    Fondaparinux (Arixtra®) is an anticoagulant that selectively inhibits activated factor X, thereby interrupting the blood coagulation cascade. In OASIS-5, a large pivotal trial in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS), subcutaneous fondaparinux 2.5 mg once...

  • Do Antiplatelet and Anticoagulation Agents Matter after Repair of Traumatic Arterial Injuries? EUGENE WANG; KENJI INABA; JAYUN CHO; BYERLY, SASKYA; ROWE, VINCENT; BENJAMIN, ELIZABETH; LYDIA LAM; DEMETRIADES, DEMETRIOS // American Surgeon;Oct2016, Vol. 82 Issue 10, p968 

    Thrombosis is a devastating complication after repair of traumatic vascular injury. Although thrombosis rates have been described, the value of anticoagulation in preventing postrepair thrombosis is unknown. We hypothesize that postoperative anticoagulation reduces thrombosis rates. A total of...

  • Anticoagulation of Pregnant Women with Mechanical Heart Valve Prosthesis: A Systematic Review of the Literature (2000-2009). Hassouna, Ahmed; Allam, Hemat // Journal of Coagulation Disorders;2010, Vol. 2 Issue 2, p1 

    Managing anticoagulation of pregnant women with mechanical heart valve prosthesis (MPHV) is now mainly limited to three alternatives: oral anticoagulants (OA) throughout pregnancy; oral anticoagulants substituted by heparin between the 6th and 12th week of gestation then resumed thereafter...

  • Towards evidence-based treatment of thrombotic antiphospholipid syndrome. Derksen, R. H. W. M.; de Groot, P. G. // Lupus;Apr2010, Vol. 19 Issue 4, p470 

    Thrombosis in the presence of persistently positive tests for antiphospholipid antibodies is termed thrombotic antiphospholipid syndrome (APS). At present, 'standard' secondary thromboprophylaxis in thrombotic APS is treatment with moderate intensity oral anticoagulants for life after a first...

  • Anticoagulation therapy of vascular thrombotic diseases and new progress of Rivaroxaban application. ZHAO Ziyuan; ZHANG Xiujun // Tianjin Medical Journal;4/1/15, Vol. 43 Issue 4, p446 

    Incidence of thrombotic disease is very high, and this disease can result in high mortality and high disability rate. Prevention and treatment of the disease mainly include: antiplatelet, anticoagulation and thrombolysis. Choice of anti-thrombotic treatment based emphasizes on individuation. As...

  • Treatment and Outcome of Intracranial Hemorrhage after Carotid Artery Stenting. Xu, Y.; Wanga, Y.; Feng, L.; Miao, Z.; Ling, F. // Interventional Neuroradiology;2009, Vol. 15 Issue 3, p316 

    Intracranial hemorrhage following carotid artery stenting (CAS) is a rare but potentially devastating complication. The present study reviewed intracranial hemorrhage cases from patients undergoing CAS in ten years to find the methods to rescue patients from this fatal complication. Patients...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics